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Flavone glycosidesAbstract Gleditsia triacanthos L. is a deciduous tree belonging to the family Fabaceae. It possesses
important biological activities as anti-mutagenic, anticancer, cytotoxic and treating rheumatoid
arthritis. The total ethanol extract (EtOHE) and successive extracts (petroleum ether, chloroform,
ethyl acetate, and aqueous ethanol) were prepared from the leaves. Eight ﬂavone glycosides and two
ﬂavone aglycones named vicenin-I (1), vitexin (2), isovitexin (3), orientin (4), isoorientin (5),
luteolin-7-O-ß-glucopyranoside (6), luteolin-7-O-ß-galactopyranoside (7), apigenin-7-O-ß-glucopy-
ranoside (8), luteolin (9) and apigenin (10) were isolated from the aqueous ethanol extract of G. tri-
acanthos L. leaves. Potent cytotoxic activity of the EtOHE extract was observed against the liver
(IC50 = 1.68 lg), breast (IC50 = 0.74 lg), cervix (IC50 = 1.28 lg), larynx (IC50 = 0.67 lg) and
colon (IC50 = 2.50 lg) cancer cell lines. Cytotoxic activity of compounds 2, 4, 6 and 8 against,
the liver, breast and colon cancer cell lines was also proved. Evaluation of the in-vivo antioxidant
activity of the EtOHE and successive extracts revealed that the highest activity was exhibited by
100 mg of EtOHE (97.89% potency) as compared with vitamin E (100% potency). Compound 6
showed 91.8% free radical scavenging activity.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Genus Gleditsia comprises 14 species of deciduous trees which
can reach a height of 20–30 m (Huxley et al., 1992). Gleditsia
species have been widely used in traditional Chinese medicine.
The fruits and thorns are used for treating apoplexy, headache,
productive cough, asthma and suppurative skin diseases
(Zhong Yao Da Ci Dian, 1979). It was reported that Gleditsia
triacanthos seed extracts can be used as a natural source of
phenolic compounds and as antioxidants, also extracts of
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treating rheumatoid arthritis, as anti-mutagenic, anticancer
and they have signiﬁcant cytotoxic activity against different
cell lines (Miguel et al., 2010). Phytochemical studies were
carried out on members of Gleditsia fruits that indicated the
presence of triterpenoidal saponins which possess anti-
inﬂammatory activity. (Yamahara et al., 1975; Shin and
Kim, 2000; Ha et al., 2008, Dai and Hou, 2006; Hou et al.,
2006). Triacanthosides saponin A1, G and C together with
Gleditschosides A, B, C, D and E were reported to be isolated
from Gleditsia fruits species (Badalbaeva et al., 1972a,b,
1973a,b). Triacanthoside C, oleanolic and echinocystic acids
were reported to be isolated from the pericarp of G. triacanthos
in addition to Gleditschosides A, B, C, D, and E (Badalbaeva
et al., 1973a). Triacanthine alkaloid was isolated from the
leaves of G. triacanthos (Panova et al.,1971; Masterova’
et al., 1977). Vitexin, luteolin, isovitexin, quercetin were
reported to be isolated from G. triacanthos (Panova and
Georgieva, 1972; Leibovici et al., 1986). Aim of the study is to
prove the cytotoxic and antioxidant activities of the plant which
were reported in folk medicine as well as isolation and identiﬁ-
cation of the ﬂavonoid compounds of the leaves (see Fig. 1).
2. Materials
2.1. Plant material
Fresh leaves of G. triacanthos L. were obtained from the Zoo
in May 2007. It was identiﬁed by Mrs. Terase Labib, plant tax-
onomist of Orman Garden, Giza, Egypt. A voucher specimen
(M 96) was deposited by Dr. Mona Marzouk and kept in the
herbarium of NRC (National Research Center).
2.2. Material for in-vitro cytotoxic activity
HepG2 (liver), MCF7 (breast), HeLa (cervix), HEp-2 (larynx)
and HCT116 (colon) cancer cell lines were obtained from the
American Type Culture Collection, University Boulevard,
Manassas, USA.
2.3. Material for in-vitro antioxidant activity
Vitamin E (a-tocopheryl acetate) (Pharco Pharmaceutical Co.)
is available in the form of gelatinous capsules each contains
400 g it was used as a reference antioxidant drug. Alloxane (Sig-
ma Co.): was used for induction of diabetes in rats. DPPH (1,1-
Diphenyl-2-picryl-hydrazil) is a relatively stable free radical.
3. Methods
3.1. Experimental
3.1.1. General procedure
The structure of the compounds was identiﬁed by spectro-
scopic methods including: UV/VIS (Ultraviolet and Visible
Absorption Spectrometer, Labomed Inc.) for measuring UV
spectral data of the isolated compounds, in the range of 200–
500 nm in methanol and with different diagnostic shift
reagents. NMR (Nuclear Magnetic Resonance Spectropho-
tometer, JEOL EX, 500 MHz for determination of 1H NMRand 125 MHz for determination of 13C NMR), ESI/MS (Elec-
trospray Ionization Mass Spectrometer, Thermo Finnigan (ion
trap)) were carried out for determination of molecular
weight of compounds, CC was carried out on Polyamide 6S
(Riedel-De-Haen AG, Seelze Haen AG, D-30926 Seelze
Hanver, Germany) and Sephadex LH-20 (Pharmazia). PC
(descending) Whatman No. 1 and 3 MM papers, using
solvent systems 15% HOAc (H2O–HOAc 85:15), BAW
(n-BuOH:HOAc:H2O 4:1:5, upper layer). Complete acid
hydrolysis for O-glycosides (6, 7, 8) was carried out & followed
by CO-chromatograph with authentic samples to identify the
aglycone and sugar moieties, the sugar unit of (1, 2, 3, 4, 5)
was determined using ferric chloride degradation (Mabry et al.,
1970). Source of solvents used for plant extraction: SDFCL
(Industrial Estate, 248 Worli Road, Mumbai-30, India).
3.2. Extraction and puriﬁcation
Dried powdered leaves of G. triacanthos L (1 kg) were exhaus-
tively extracted with solvents of increasing polarities, petro-
leum ether (Pet. ether 49 g), chloroform (Chlo. 21 g), ethyl
acetate (EtOAc: 14 g) and 70% aqueous ethanol (AEtOH:
135 g) at room temperature, the previous extracts were dried
under reduced pressure and subjected to in-vivo antioxidant as-
say. 80 g of AEtOH was dissolved in water then applied on the
top of polyamide S6 column (120 · 5 cm) eluted by solvent sys-
tems of decreasing polarities starting from 100% water to
100% methanol. A total of 100 fractions were collected
(250 ml each). Similar fractions were combined according to
PC analysis (1MM) sheets using the following eluents: n-buta-
nol:acetic acid:water (4:1:5), acetic acid:water (15:85). Compo-
nents were detected under UV and by spraying with AlCl3 to
give six main pooled fractions (A–F). Fraction A was chro-
matographed on cellulose column eluted by 10% MeOH-
H2O to give one main subfraction, puriﬁcation on Sephadex
using MeOH-H2O (10%) yielded compounds 1 (10 mg). B
was subjected to cellulose column eluted by saturated butanol
to give one main subfraction which was puriﬁed on silica gel
column eluted by CHCl3: MeOH 9:1 to give compounds 2
and 3 (20, and 18 mg respectively). C was chromatographed
on PPC (3 MM) using acetic acid: water (15:85) followed by
Sephadex and eluted by saturated butanol to give compounds
4 and 5 (20, and 10 mg). D was chromatographed on PPC
(3 MM) using acetic acid:water (15:85) and puriﬁed on Sepha-
dex with saturated butanol to give compound 6 and 7 (15, and
15 mg). E was puriﬁed on Sephadex using MeOH-H2O(10%)
to give compound 8. F was subjected to Sephadex using
MeOH-H2O (1:1) to yield compounds 9 (12 mg) and 10
(15 mg). Final puriﬁcation of all compounds was achieved by
Sephadex LH20 column using MeOH as eluent.
3.2.1. Compound 1 (vicenin-I)
Negative ESI-MS Molecular ion peak (M–H) at m/z 563, the
ESI-MS fragmentation pattern: 503, 473, 443, 383. UV: k max
(nm): MeOH: 272, 327; NaOMe: 282, 333 (sh), 390; AlCl3: 305,
345, 389; AlCl3/HCl: 305, 345, 489; NaOAc: 281, 307, 392;
NaOAc/H3BO3: 279, 344.
1H NMR: (500 MHz, DMSO-d6, d
ppm): 6.30(1H, s, H-3), 7.83 (2H, d, J= 8.4 Hz, H-20/H-60),
6.78(2H, d, J= 8.4 Hz, H-30/H-50), 8-C-b-Glc: 4.35 (1H, d,
J= 9.8 Hz, H-10 0 0), 6-C-b-xylose: 3.8 (1H, d, J= 9.6 Hz
H-100, Xylose).
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Figure 1 Chemical structure of compounds 1–10.
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550 R.S. Mohammed et al.3.2.2. Compound 2: vitexin (apigenin 8-C-b-glucopyranoside)
UV: k max (nm) MeOH: 270, 333; NaOMe: 285, 337, 391;
AlCl3: 264sh, 278, 303, 352, 383; AlCl3/HCl: 262sh, 280, 302,
352, 383; NaOAc: 278, 299sh, 375; NaOAc/H3BO3: 272,
304sh, 355.
1H NMR (500 MHz, DMSO-d6, d ppm): 6.59 (1H, s, H-3),
6.30 (1H, d, J= 2.3 Hz, H-6), 7.81 (2H, d, J= 8.4 Hz,
H-20/H-60), 6.87 (2H, d, J= 8.4 Hz, H-30/H-50), 4.52 (1H, d,
J= 9.8 Hz, H-100), 3.2–3.9 (m, H-200- H-400, H-500, H600).
13C NMR (125 MHz DMSO-d6, ppm): 164.37 (C-2), 102.38
(C-3), 181.68 (C-4), 161.15 (C-5), 94.92 (C-6) 163.28 (C-7),
109.69 (C-8), 157.12 (C-9), 102.94 (C-10), 121.68 (C-10),
128.69 (C-20), 116.56 (C-30), 161.83 (C-40), 116.56 (C-50),
128.69 (C-60), 74.00 (C-100), 70.72 (C-200), 79.63 (C-300), 70.94
(C-400), 81.80 (C-500), 61.73 (C-600).
3.2.3. Compound 3: isovitexin (apigenin 6-C-b-
glucopyranoside)
UV k max (nm): MeOH: 270, 333; NaOMe: 279, 331, 396;
AlCl3: 263sh, 278, 280, 303, 338sh, 380; AlCl3/HCl: 262sh,
279, 302, 341, 378; NaOAc: 280, 300, 379;
NaOAc/H3BO3: 271,320sh, 345.
1H NMR (500 MHz, DMSO-d6, d ppm): 6.71 (1H, s, H-3),
6.50 (1H, d, J= 2.3 Hz, H-8), 7.86 (2H, d, J= 8.4 Hz,
H-20/H-60), 6.89 (2H, d, J= 8.4 Hz, H-30/H-50), 4.54 (1H, d,
J= 9.8 Hz, H-100), 4.0 (1H, H-200), 3.7–3.1 (m, H-300, H-400,
H-500, H-60).
13C NMR (125 MHz DMSO-d6, ppm):163.00 (C-2), 102.62
(C-3), 181.78 (C-4), 160. 50 (C-5), 103.11 (C-6) 163.35 (C-7),
93.97 (C-8), 156.12 (C-9), 103.50 (C-10), 120.97 (C-10),
128.30(C-20), 115.90 (C-30), 161.11 (C-40), 115.90 (C-50),
128.30 (C-60), 72.94 (C-100), 70.06 (C-200), 78.86 (C-300), 70.94
(C-400), 81.43 (C-500), 61.33 (C-600).
3.2.4. Compound 4: orientin (luteolin 8-C-b-glucopyranoside)
UV k max (nm): MeOH: 254, 269, 270sh, 350; NaOMe: 269,
337sh, 406; AlCl3: 275, 346, 422; AlCl3/HCl: 275, 298sh,
355, 341, 382; NaOAc: 277, 318sh, 399; NaOAc/H3BO3:
264, 376.
1H NMR (500 MHz, DMSO-d6, d ppm).: 6.42 (1H, s,
H-3), 5.97 (1H, d, J= 2.3 Hz, H-6), 7.33 (1H, d,
J= 2.3 Hz, H-20), 7.40 (1H, m, H-60), 6.72, (1H, d,
J= 8.4 Hz, H-50), 4.68 (1H, d, J= 9.95, H-100), 3.2–3.9 (m,
H-200, H-300, H-400,H-500, H-600).
3.2.5. Compound 5: isoorientin (luteolin-6-C-b-
glucopyranoside)
UV k max (nm): MeOH: 257, 270sh, 350; NaOMe: 278, 335sh,
410; AlCl3: 275, 303,425; AlCl3/HCl: 257sh, 278,300sh, 356;
NaOAc: 271, 407; NaOAc /H3BO3: 268, 381.
1H NMR (500 MHz, DMSO-d6, d ppm): 6.61(1H, s, H-3),
6.23 (1H, d, J= 2.3, H-8), 7.42 (1H, d, J= 2.3, H-20), 6.82
(1H, d, J= 8.4, H-50), 7.49 (m, H-60), 4.65,(1H, d, J= 9.95,
H-100), 3.2–3.9(m,H-200, H-300, H-400, H-500, H-600).
13C NMR (125 MHz DMSO-d6, ppm): 164.4 (C-2), 102.89
(C-3), 182.55 (C-4), 160. 88 (C-5), 105.00 (C-6) 164.62 (C-7),
98.63 (C-8), 156.51 (C-9), 104.48 (C-10), 122.46 (C-10),
114.42 (C-20), 146.33 (C-30), 150.14 (C-40), 116.17 (C-50),
119.89 (C-60), 73.86 (C-100), 71.20 (C-200), 79.20 (C-300), 71.28
(C-400), 82.43 (C-500), 62.14 (C-600).3.2.6. Compound 6: (luteolin -7-O-b-glucopyranoside)
UV k max (nm): MeOH: 253, 265sh, 348; NaOMe: 263, 300sh,
390; AlCl3: 273, 295,325,430; AlCl3/HCl: 273, 294,358, 377;
NaOAc: 255, 266sh, 365sh, 400; NaOAc/H3BO3: 255, 375.
1H NMR (500 MHz, DMSO-d6, d ppm). 6.61(1H, s, H-3),
6.42 (1H, d, J= 2.3 Hz, H-6), 6.90 (1H, d, J= 2.3 Hz, H-8),
7.43 (1H, d, J= 2.3 Hz, H-20), 7.40(1H, dd, J= 2.3, 8.4 Hz,
H-6‘), 6.92 (1H, J= 8.4 Hz, H-50), 5.08(1H, d, J= 7.65 Hz,
H-100), 3.5–4.1 (mH-200, H-300, H-400, H-500, H-600).
3.2.7. Compound 7: (luteolin -7-O-b-galactopyranoside)
UV k max (nm) as in compound 6.
1H NMR(500 MHz, DMSO-d6, d ppm).: 6.61, (1H, s, H-3),
6.43(1H, d, J= 2.3 H-6), 6.82 (1H, d, J= 2.3 H-8),7.44(1H,
d, J= 2.3, H-20), 6.92 (1H, d J= 8.4, H-50) 7.40, (1H, dd,
J= 2.3, 8.4, H-60), 5.08 (1H, d, J= 7.65, H-100), 3.4–4.1 (H-
200, H-300, H-400, H-500, H-600).
3.2.8. Compound 8: (apigenin-7-O-b-glucopyranoside)
UV k max (nm) as in compound 2.
1H NMR (500 MHz, DMSO-d6, d ppm).: 6.41 (1H, s, H-3),
6.61 (1H, d, J= 2.3 Hz, H-6), 6.77(1H, d, J= 2.3 Hz, H-8),
7.81 (2H, d, J= 8.4 Hz, H-20/H-60), 6.89 (2H, d, J= 8.4 Hz,
H-30/H-50), 5.08(IH, d, J= 6.85 Hz, H-100), 3.4–3.85 (H-200,
H-300, H-400, H-500, H-600).
Compound 9: (luteolin).
Compound 10:(apigenin).
3.3. Investigation of antioxidant activity
3.3.1. In-vivo antioxidant activity
Glutathione (GSH) is the body’s most abundant natural anti-
oxidant. Diabetes is usually accompanied by increased produc-
tion of free radicals and impaired antioxidant defenses. A
simultaneous fall in blood GSH was observed following the
injection of diabetogenic doses of alloxan into rats. Therefore,
blood glutathione was estimated in alloxan-induced diabetic
rats for evaluating the antioxidant activity (Oberley, 1988;
Maritim et al., 2003). In-vivo antioxidant activity was carried
out according to Eliasson and Samet, 1969. At the end of
the experiment, blood glutathione was estimated using bio-
diagnostic kits (Beutler et al., 1963). The results were expressed
as mean ± S.E. The data were statistically analyzed using Stu-
dent’s ‘‘t’’ test (Sendecor and Cohran, 1982). Results are con-
sidered statistically signiﬁcant with P> 0.01.
3.3.2. In-vitro antioxidant activity (Free radical scavenging
activity)
In-vitro antioxidant activity by DPPH is used to evaluate the
free radical scavenging activity of compounds 2, 4, 6 and 8 fol-
lowing the method of Shimada et al (1992).
3.4. Investigation of cytotoxic activity
Cytotoxic activity of the EtOHE against ﬁve human tumor cell
lines was tested using the method of Skehan et al. (1990). Com-
pounds 2, 4, 6 and 8 were evaluated for their cytotoxic activi-
ties against three tumor cell lines by MTT assay (Mosmann,
1983). The method was carried out according to Thabrew
et al. (1997).
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et al., 1990)
Cells were plated in 96-multi-well plate (104 cells/well) for 24 h
before treatment with the total alcohol extract of the plant to
allow attachment of the cell to the wall of the plate.
Different concentrations of the extract under test (0, 1, 2.5,
5 and 10 lg/mL) were added to the cell monolayer, triplicate
wells being prepared for each individual dose.
Monolayer cells were incubated with the total alcohol ex-
tract of the plant for 48 h at 37 C and in atmosphere of 5%
CO2. After 48 h, cells were ﬁxed, washed and stained with sul-
forhodamine B (SRB) stain (Sigma).
Excess stain was washed with acetic acid and attached stain
was recovered with tris–EDTA buffer (Sigma). Color intensity
was measured in an ELISA reader. The relation between sur-
viving fraction and the plant extract concentration was plotted
to get the survival curve of each tumor cell line after treatment.
The potency was compared with reference (Cisplatin (Glaxo),
DOX).
3.4.2. MTT assay (Mosmann, 1983)
Cell viability was assessed by the mitochondrial dependent
reduction of the yellow MTT (3-(4,5-dimethyl thiazol-2-yl)-
2,5-diphenyl tetrazolium bromide) to the purple formazan
(Mosmann, 1983).The method was carried out according to
Thabrew et al. (1997).
Cells were batch cultured for 10 days, then seeded at a con-
centration of 10 · 103 cells/well in fresh complete growth med-
ium in 96-well microtiter plastic plates at 37 C for 24 h under
5% CO2 using a water jacketed carbon dioxide incubator
(Sheldon, TC2323, Cornelius, OR, USA).
Media were aspirated, fresh medium (without serum)
was added and cells were incubated either alone (negative
control) or with different concentrations of the samples to give
a ﬁnal concentration of 100–50-25–12.5–6.25–3.125–0.78 and
1.56 lg/ml.
Cells were suspended in RPMI 1640 medium[(for HepG2
and HT29 – DMEM for MCF 7)], 1% antibiotic–antimycotic
mixture (10,000 U/ml potassium penicillin, 10,000 lg/ml
streptomycin sulfate and 25 lg/ml amphotericin B) and 1%
L-glutamine in 96-well ﬂat bottom microplate at 37 C under
5% CO2. After 48 h of incubation, the medium was
aspirated, 40 ll MTT salt (2.5 lg/ml) was added to each well
and incubation for further four hours at 37 C under 5%
CO2.
200 lL of 10% sodium dodecyl sulfate (SDS) in deionized
water was added to each well and incubated overnight at
37 C to stop the reaction and dissolve the formed crystals.
A positive control which composed of 100 lg/ml of Annona
cherimolia extract was used as a known cytotoxic natural agent
which gives 100% lethality under the same conditions. The
absorbance was then measured using a microplate multi-well
reader (Bio-Rad Laboratories Inc., model 3350, Hercules, Cal-
ifornia, USA) at 595 nm and a reference wavelength of
620 nm. A statistical signiﬁcance was tested between samples
and negative control (cells with vehicle) using independent t-
test by SPSS 11 program. DMSO is the vehicle used for disso-
lution of the plant extracts and its ﬁnal concentration on the
cells was less than 0.2%.
The percentage of change in viability was calculated
according to the formula:½ðReading of extractReading of negative controlÞ1100
A probit analysis was carried out for IC50 and IC90 determina-
tion using SPSS 11 program. All the following procedures were
done in a sterile area using a laminar ﬂow cabinet biosafety
class II level (Baker, SG403INT, Sanford, ME, USA).4. Results and discussion
4.1. Identiﬁcation of the isolated compounds
The phytochemical investigation of the AEtOH of G.
triacanthos L leaves afforded ten ﬂavonoids (1–10), they
are vicenin-I (1), vitexin (2), isovitexin (3), orientin (4), iso-
orientin (5), luteolin-7-O-ß-glucopyranoside (6), luteolin-7-
O-ß galactopyranoside (7), apigenin-7-O-ß-glucopyranoside
(8), luteolin (9) and apigenin (10) their structure elucidation
was carried out through Rf-values, color reactions, chemical
investigations (complete acid hydrolysis and ferric acid
degradation) and spectral investigations (UV, NMR and
MS) (Mabry et al., 1970; Markham, 1982; Agrawal,
1989). Spectral data of the known ﬂavonoids were in good
accordance with those previously published (Agrawal, 1989;
Markham and Geiger, 1994). Compounds 1, 4, 5, 6, 7, 8
and 10 were isolated for the ﬁrst time from the plant under
investigation.
4.2. Biological study
4.2.1. In-vivo antioxidant activity
The EtOHE of G. triacanthos leaves was subjected to LD50
determination it was found to be 6.6 g/kg body weight. In-vivo
antioxidant activity of the EtOHE and successive extracts of G.
triacanthos L. leaves (Table 1) were evaluated as indicated by
the increase in glutathione level as compared with diabetic
control. The result showed that EtOH at 100 mg showed the
highest antioxidant activity (64.05% of change from diabetic
control) followed by pet. ether (61.75%), ethyl acetate
(61.21%), chloroform (58.989%) and AEtOH (57.14%)
extract.
4.2.2. In-vitro antioxidant activity (Free radical scavenging
activity)
In-vitro antioxidant activity of compounds 2, 4, 8 showed no
antioxidant activity while 6 showed 91.8% free radical scav-
enging activity.
4.2.3. 3.2.2.Cytotoxic activity
Potent cytotoxic activity (Table 2) of the AEtOH of G. triacan-
thos L. leaves was observed against, the liver (IC50 = 1.68 lg),
breast (IC50 = 0.74 lg), cervix (IC50 = 1.28 lg), larynx
(IC50 = 0.67 lg) and colon cancer cell lines (IC50 = 2.50 lg).
Compounds 2, 4, 6 and 8 were screened for their cytotoxic
activities on the breast, liver, and colon cell lines (Table 3)
compound 2 caused 73.5%, 30.6%, 51.5% death of the breast,
liver and colon cell lines respectively. Compound 4 caused
40.2% death of breast and has no cytotoxic activity against
the liver or colon cell line. Compound 6 caused 36.1%, 0%,
15.6% death of the breast, liver and colon cell. Compound 8
caused 41.3% death of the breast while it showed no cytotoxic
Table 1 In vivo antioxidant activity of EtOH and successive extracts of G. triacanthos L. leaves.
Group (dose in mg/kg b wt) Blood glutathione (Mean ± SE) % of change from diabetic control Relative potency%
Diabetic (control) 21.7 ± 0.3* – –
Diabetic + EtOH (50) 32.2 ± 0.8* 48.38 73.94
Diabetic + EtOH (100) 35.6 ± 1.2* 64.05 97.89
Diabetic + Pet. ether (100) 35.1 ± 1.1* 61.75 95.90
Diabetic + Ch.(100) 34.5 ± 0.8* 58.98 90.14
Diabetic + EtOAc (100) 35.2 ± 0.9* 61.21 95.07
Diabetic + AEtOH (100) 34.1 ± 0.6* 57.14 87.33
Diabetic + Vit E (75) 35.9 ± 0.9* 65.43 100
* Signiﬁcantly different from the diabetic control at p< 0.01.
Table 2 Cytotoxicitc activity of the EtOHE of G. triacanthos L. leaves.
Concentration (lg/ml) (% of Dead cells)
Cell lines
Hep G2 MCF7 HeLa HEp-2 HCT116
1 37 61 41 64 25
2.5 62 72 72 67 50
5 89 80 80 72 65
10 91 80 89 76 79
Cisplatin
1 40 89 10 80 75
2.5 41 87 58 77 70
5 48 87 83 69 67
10 48 86 94 73 63
Table 3 Cytotoxicic activity of compounds 2, 4, 6 and 8.
Cell line Conc lg/ml Doxorubicin % of Dead cells
Compounds
2 4 6 8
Hep G2 12.5 32.4 0 0 0 0
25 60.2 0 0 0 0
50 97.2 9.4 0 0 0
100 100 30.6 0 0 0
MCF7 12.5 32.7 31.7 0.7 10.9 3.6
25 57.6 47 14.1 16.7 22.1
50 84.3 51.1 22.5 26.2 33.1
100 100 73.5 40.2 36.1 41.3
HCT116 12.5 18.4 0 0 0 0
25 35.4 9.4 0 0 0
50 65.2 23.4 0 3.5 0
100 100 51.2 0 15.6 0
552 R.S. Mohammed et al.activity against the liver or colon cancer cell line. All these
activities were obtained at100 lg/ml.5. Conclusion
Ten known ﬂavonoids, seven of them were isolated for the
ﬁrst time from the dried leaves of G. triacanthos L. Their
structures were based on apigenin and luteolin nucleolus.The EtOHE of the plant has potent cytotoxic activity against,
the larynx, breast, cervix, liver and colon cancer cell lines this
proves the uses of the plant in folk medicine as anticancer.
EtOHE has a good antioxidant activity supporting the use
of the plant as a natural source of phenolic compounds
and as antioxidant.
This work was extracted from the MSC Thesis of Wedian
El-Sayed Mohamed Ashour, Pharmacognosy Department,
National Research Centre (Ashour, 2012).
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